|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating Activities | ||||
| Net earnings | ||||
| Adjustments for: | ||||
| Depreciation and amortization | ||||
| Equity earnings and impairment of associates and joint ventures | ||||
| Deferred income taxes | ||||
| Share-based compensation expense | ||||
| Loss on financial instruments | ||||
| Derecognition and unrealized loss (gain) on redemption options | ||||
| (Gain) on sale of PP&E | ||||
| Impairment of EI assets | ||||
| Impairment of goodwill (Note 12) | ||||
| Debt extinguishment costs of the 2027 Notes | ||||
| Adjustments to reconcile profit (loss) other than changes in working capital | ||||
| Net change in working capital and other | ||||
| Cash provided by operating activities | ||||
| Investing Activities | ||||
| Net cash acquired from Acquisition (Note 6) | ||||
| Additions to: | ||||
| PP&E | ||||
| Energy infrastructure assets (Note 11) | ||||
| EI assets - operating leases | ||||
| Intangible assets | ||||
| Proceeds on disposal of: | ||||
| PP&E | ||||
| Energy infrastructure assets (Note 11) | ||||
| Purchase of short-term investments | ||||
| Investment in associates and joint ventures | ||||
| Dividends received from associates and joint ventures | ||||
| EI assets - operating leases | ||||
| Net (purchases) of financial instruments | ||||
| Net change in working capital associated with investing activities | ||||
| Cash used in investing activities | ||||
| Financing Activities | ||||
| Net proceeds from (repayment of) the Revolving Credit Facility (Note 20) | ||||
| Issuance of the Notes | ||||
| Issuance (repayment) of the Term Loan (Note 20) | ||||
| Repayment of assumed debt on Acquisition | ||||
| Repayment of the Notes on Acquisition | ||||
| Repayment of the Bank Facility on Acquisition | ||||
| Net proceeds from (repayment of) the Asset-Based Facility on Acquisition | ||||
| Net proceeds from the Revolving Credit Facility | ||||
| Repayment of the Revolving Credit Facility | ||||
| Repayment of the 2027 Notes | ||||
| Repayment of the Term Loan (Note 17) | ||||
| Issuance of the 2031 Notes | ||||
| Repayment of the Term Loan | ||||
| Lease liability principal repayment | ||||
| Dividends | ||||
| Stock option exercises | ||||
| Shares repurchased - NCIB | ||||
| Deferred transaction costs | ||||
| Cash used in financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents denominated in foreign currencies | ||||
| Decrease in cash and cash equivalents | ||||
| Cash and cash equivalents, beginning of period | ||||
| Cash and cash equivalents, end of period | ||||
Loading...